Trials / Completed
CompletedNCT02096289
Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
A Phase I Trial Evaluating Oral Thioridazine in Combination With Intermediate Dose Cytarabine in Patients 55 Years and Older With Acute Myeloid Leukemia Who Have Relapsed or Have Refractory Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Ontario Clinical Oncology Group (OCOG) · Academic / Other
- Sex
- All
- Age
- 55 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I trial investigating the safety of using thioridazine in addition to cytarabine in elderly patients with relapsed or refractory Acute Myeloid Leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thioridazine |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2014-03-26
- Last updated
- 2016-12-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02096289. Inclusion in this directory is not an endorsement.